Keane Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$571K Sell
55,134
-105,163
-66% -$1.12M 6.01% 9
2015
Q3
$1.71M Sell
160,297
-14,075
-8% -$171K 2.25% 18
2015
Q2
$2.06M Hold
174,372
2.12% 19
2015
Q1
$1.66M Buy
174,372
+15,622
+10% +$161K 1.62% 31
2014
Q4
$1.63M Buy
158,750
+7,500
+5% +$65.1K 1.57% 32
2014
Q3
$1.2M Hold
151,250
1.16% 47
2014
Q2
$1.21M Sell
151,250
-66,981
-31% -$500K 1.13% 48
2014
Q1
$1.88M Buy
+218,231
New +$2.01M 1.43% 26

Other funds holding ACLS

Keane Capital Management's ACLS Position: Q4 2015 in Review

Keane Capital Management reduced its Axcelis (ACLS) stake by 66% in Q4 2015, selling an estimated $1.12M and leaving 55,134 shares worth $571K. The position accounts for 6.01% of the portfolio, ranked #9.

Keane Capital Management first reported a position in ACLS in Q1 2014 and has held it in 8 quarters since. The position peaked at $2.06M in Q2 2015. 112 funds tracked by Wall St. Rank hold ACLS as of Q4 2015.

  • Keane Capital Management held 55,134 shares of Axcelis worth $571K as of Q4 2015.
  • Keane Capital Management sold 105,163 Axcelis shares in Q4 2015, an estimated $1.12M.
  • Axcelis made up 6.01% of Keane Capital Management's portfolio in Q4 2015, its #9 holding.
  • Keane Capital Management first reported a position in Axcelis in Q1 2014 and has held it in 8 quarters since.
  • Keane Capital Management's Axcelis position peaked at $2.06M in Q2 2015.
  • 112 funds tracked by Wall St. Rank held Axcelis as of Q4 2015.

Based on Keane Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.